Evogene Ltd. (EVGN)
$0.38-2.56%Close
SELLCRISIS · day 21
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3M
- Beta
- 0.72
- P/E (TTM)
- -0.43
- Short % float
- 10.04%
- Days to cover
- 1.0
- SI change
- +1541.9%
- 1W
- -7.32%
- 1M
- -28.30%
- vs SPY 1W
- -6.34%
- vs SPY 1M
- -30.17%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 5
- GROWTH
- 24
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-
REV YoY-
ROE-
EPS YoY-
ROA-67.7%
GROSS-14
OP-1020
NET-696
[VALUATION]
P/E TTM-0.43
P/E FWD-
SECTOR PE20.48
INDUSTRY PE13.99
P/B-1.45
P/FCF-
EV/EBITDA0.32
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO3.57
ND/EBITDA-
BETA0.72
Company news
FAQ
- What is LOPJLB’s current signal on EVGN?
- LOPJLB’s latest quantitative signal on Evogene Ltd. (EVGN) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is EVGN in?
- Evogene Ltd. (EVGN) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Evogene Ltd. (EVGN) do?
- Evogene Ltd., along with its subsidiaries, operates as a computational biology firm. Its core activity involves the discovery and advancement of products across diverse life-science sectors, such as human health and agriculture, primarily leveraging its proprietary Computational Predictive Biology (CPB) platform. This platform, built on deep biological insights, big data analytics, and artifici…